BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashrafizadeh M, Zarrabi A, Hashemi F, Moghadam ER, Hashemi F, Entezari M, Hushmandi K, Mohammadinejad R, Najafi M. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sci 2020;256:117984. [PMID: 32593707 DOI: 10.1016/j.lfs.2020.117984] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Mollaei M, Hassan ZM, Khorshidi F, Langroudi L. Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells? Transl Oncol 2021;14:101056. [PMID: 33684837 DOI: 10.1016/j.tranon.2021.101056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zheng Y, Yang X, Tan J, Tian R, Shen P, Cai W, Liao H. Curcumin suppresses the stemness of non‐small cell lung cancer cells via promoting the nuclear‐cytoplasm translocation of TAZ. Environmental Toxicology 2021;36:1135-42. [DOI: 10.1002/tox.23112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Paskeh MDA, Mirzaei S, Gholami MH, Zarrabi A, Zabolian A, Hashemi M, Hushmandi K, Ashrafizadeh M, Aref AR, Samarghandian S. Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies. Biomed Pharmacother 2021;144:112335. [PMID: 34700233 DOI: 10.1016/j.biopha.2021.112335] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Riedel J, Calienni MN, Bernabeu E, Calabro V, Lázaro-martinez JM, Prieto MJ, Gonzalez L, Martinez CS, Alonso SDV, Montanari J, Evelson P, Chiappetta DA, Moretton MA. Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane®. Journal of Drug Delivery Science and Technology 2021;62:102343. [DOI: 10.1016/j.jddst.2021.102343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Barua N, Buragohain AK. Therapeutic Potential of Curcumin as an Antimycobacterial Agent. Biomolecules 2021;11:1278. [PMID: 34572491 DOI: 10.3390/biom11091278] [Reference Citation Analysis]
6 Mirzaei S, Abadi AJ, Gholami MH, Hashemi F, Zabolian A, Hushmandi K, Zarrabi A, Entezari M, Aref AR, Khan H, Ashrafizadeh M, Samarghandian S. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets. Eur J Pharmacol 2021;908:174344. [PMID: 34270987 DOI: 10.1016/j.ejphar.2021.174344] [Reference Citation Analysis]
7 Mirzaei S, Gholami MH, Zabolian A, Saleki H, Farahani MV, Hamzehlou S, Far FB, Sharifzadeh SO, Samarghandian S, Khan H, Aref AR, Ashrafizadeh M, Zarrabi A, Sethi G. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacol Res 2021;171:105759. [PMID: 34245864 DOI: 10.1016/j.phrs.2021.105759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 El-Far AH, Mohamed HH, Elsabagh DA, Mohamed SA, Noreldin AE, Al Jaouni SK, Alsenosy AA. Eugenol and carvacrol attenuate brain D-galactose-induced aging-related oxidative alterations in rats. Environ Sci Pollut Res Int 2022. [PMID: 35182345 DOI: 10.1007/s11356-022-18984-8] [Reference Citation Analysis]
9 Jiang S, Fu Y, Zhang X, Yu T, Lu B, Du J. Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals. Front Bioeng Biotechnol 2021;9:799806. [PMID: 34957085 DOI: 10.3389/fbioe.2021.799806] [Reference Citation Analysis]
10 Jin T, Zhang Y, Botchway BOA, Zhang J, Fan R, Zhang Y, Liu X. Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways. Food Chem Toxicol 2022;:113091. [PMID: 35526734 DOI: 10.1016/j.fct.2022.113091] [Reference Citation Analysis]
11 Moballegh Nasery M, Varzandeh M, Pahlavanneshan S, Mohamadi N, Sarhadi S, Samareh Fekri H, Mohammadinejad R, Ahn KS. Curcumin: A potential therapeutic natural product for adenocarcinomas. Phytochemistry Letters 2022;49:45-55. [DOI: 10.1016/j.phytol.2022.02.013] [Reference Citation Analysis]
12 Deldar Abad Paskeh M, Asadi S, Zabolian A, Saleki H, Khoshbakht MA, Sabet S, Naghdi MJ, Hashemi M, Hushmandi K, Ashrafizadeh M, Mirzaei S, Zarrabi A, Sethi G. Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies. Int J Mol Sci 2021;22:11669. [PMID: 34769099 DOI: 10.3390/ijms222111669] [Reference Citation Analysis]
13 Rana P, Shrama A, Mandal CC. Molecular insights into phytochemicals-driven break function in tumor microenvironment. J Food Biochem 2021;:e13824. [PMID: 34219240 DOI: 10.1111/jfbc.13824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Škubník J, Pavlíčková V, Ruml T, Rimpelová S. Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy. Plants (Basel) 2021;10:569. [PMID: 33802861 DOI: 10.3390/plants10030569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Ximenis M, Mulet J, Sala S, Sala F, Criado M, González-Muñiz R, Pérez de Vega MJ. Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators. Int J Mol Sci 2021;22:973. [PMID: 33478095 DOI: 10.3390/ijms22020973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yang T, Chen Y, Xu J, Li J, Liu H, Liu N. Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis. BMC Complement Med Ther 2022;22:21. [PMID: 35078445 DOI: 10.1186/s12906-021-03487-9] [Reference Citation Analysis]
17 Mao C, Zeng X, Zhang C, Yang Y, Xiao X, Luan S, Zhang Y, Yuan Y. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Front Cell Dev Biol 2021;9:612451. [PMID: 33644048 DOI: 10.3389/fcell.2021.612451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ashrafizadeh M, Kumar A, Aref AR, Zarrabi A, Mostafavi E. Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. IJN 2022;Volume 17:1229-53. [DOI: 10.2147/ijn.s350250] [Reference Citation Analysis]
19 Patra S, Pradhan B, Nayak R, Behera C, Rout L, Jena M, Efferth T, Bhutia SK. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. Semin Cancer Biol 2021;73:310-20. [PMID: 33152486 DOI: 10.1016/j.semcancer.2020.10.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
20 Ali P, Kirmani SAK, Al Rugaie O, Azam F. Degree-based topological indices and polynomials of hyaluronic acid-curcumin conjugates. Saudi Pharm J 2020;28:1093-100. [PMID: 32922140 DOI: 10.1016/j.jsps.2020.07.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
21 Zheng Y, Wang Y, Xia M, Gao Y, Zhang L, Song Y, Zhang C. The combination of nanotechnology and traditional Chinese medicine (TCM) inspires the modernization of TCM: review on nanotechnology in TCM-based drug delivery systems. Drug Deliv Transl Res 2021. [PMID: 34260049 DOI: 10.1007/s13346-021-01029-x] [Reference Citation Analysis]
22 Abd El-Hameed NM, Abd El-Aleem SA, Khattab MA, Ali AH, Mohammed HH. Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH). Life Sci 2021;285:119983. [PMID: 34599938 DOI: 10.1016/j.lfs.2021.119983] [Reference Citation Analysis]
23 Saeed MEM, Yücer R, Dawood M, Hegazy MF, Drif A, Ooko E, Kadioglu O, Seo E, Kamounah FS, Titinchi SJ, Bachmeier B, Efferth T. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors. IJMS 2022;23:3966. [DOI: 10.3390/ijms23073966] [Reference Citation Analysis]
24 Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, Raee P, Aghamiri S, Ashrafizadeh M, Aref AR, Hamblin MR, Hushmandi K, Zarrabi A, Sethi G. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res 2021. [PMID: 34697839 DOI: 10.1002/ptr.7305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yu C, Yang B, Najafi M. Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy. Basic Clin Pharmacol Toxicol 2021. [PMID: 34473898 DOI: 10.1111/bcpt.13648] [Reference Citation Analysis]
26 Zhang K, Li J, Xin X, Du X, Zhao D, Qin C, Han X, Huo M, Yang L, Yin L. Dual Targeting of Cancer Cells and MMPs with Self-Assembly Hybrid Nanoparticles for Combination Therapy in Combating Cancer. Pharmaceutics 2021;13:1990. [PMID: 34959271 DOI: 10.3390/pharmaceutics13121990] [Reference Citation Analysis]
27 Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I, Shirvani A, Zarrabi A, Azedi F, Dehshahri A, Aghaei Afshar A, Aghaabbasi K, Pardakhty A, Mohammadinejad R, Kesharwani P. Chitosan: A versatile bio-platform for breast cancer theranostics. J Control Release 2021;341:733-52. [PMID: 34906606 DOI: 10.1016/j.jconrel.2021.12.012] [Reference Citation Analysis]